← Back

Wire · regulatory

AMA Opposes HHS Proposal to Expand Access to Unapproved Peptides

Published

18 November 2026

Topic

regulatory

◆ Sectors

Healthtech Infrastructure

◆ Geography

United States

◆ Source

Read at southfloridahospitalnews.com →

◆ Verified

Fusion42 · 18 November 2026 · Fusion42 review

The American Medical Association (AMA) opposes a US Department of Health and Human Services (HHS) proposal to allow compounded use of unapproved peptides, citing patient safety risks and calling for these substances to undergo full FDA review.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You must prepare for potential tightening of FDA approval standards on compounded peptides as the AMA pushes back against loose regulations. This raises the bar for safety proof before market access in peptide-based treatments.

◆ Coverage

1 source · 18 Nov 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructureamahhspeptidespatient-safetyfda-approvaldrug-regulation